Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 study evaluating SAR444656 versus placebo in adults with moderate-to-severe hidradenitis suppurativa was terminated. The document reports the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• SAR444656

Snippet

Sponsor: Sanofi | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: TERMINATED